ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,894Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 212

$322K Total Retail Price of All Prescriptions

Rank: 42 out of 212

324 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 324 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 324 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 5,689 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
LISINOPRIL 353 281 1 2
SIMVASTATIN 265 209 2 1
LOSARTAN POTASSIUM 255 232 3 4
ATORVASTATIN CALCIUM 250 212 4 6
LEVOTHYROXINE SODIUM 217 187 5 7
AMLODIPINE BESYLATE 216 193 6 3
HYDROCHLOROTHIAZIDE 187 187 7 8
METFORMIN HCL 176 121 8 5
PRAVASTATIN SODIUM 162 146 9 15
METOPROLOL SUCCINATE 158 134 10 14
FUROSEMIDE 155 147 11 11
OMEPRAZOLE 150 138 12 9
HYDROCODONE-ACETAMINOPHEN 140 58 S3 13 10
LOVASTATIN 138 137 14 12
ZOLPIDEM TARTRATE 113 45 15 26
METOPROLOL TARTRATE 112 100 16 17
NIFEDIAC CC 107 101 17 76
NIFEDIPINE ER 102 78 18 77
ATENOLOL 100 95 19 13
ALLOPURINOL 92 83 20 18
DIOVAN 90 79 21 32
DONEPEZIL HCL 85 85 22 25
WARFARIN SODIUM 82 57 23 19
POTASSIUM CHLORIDE 82 73 23 27
GLIPIZIDE XL 79 58 25 88
GLIPIZIDE 79 57 25 38
GLIPIZIDE ER 70 64 27 55
DIGOXIN 66 53 28 41
METFORMIN HCL ER 66 43 28 34
GABAPENTIN 61 47 30 22
SERTRALINE HCL 57 32 31 47
TRIAMTERENE-HCTZ 56 45 32 106
TAMSULOSIN HCL 56 56 32 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.